Both in Pharmaceuticals
Moleculin Biotech vs Vistagen Therapeutics
Over the past year MBRX returned −96.8% and VTGN returned −96.0%; their daily moves had a correlation of 0.06.
MBRX −96.8% VTGN −96.0%Growth of $1, one year, split-adjusted
| Metric | MBRX | VTGN |
|---|---|---|
| Price | $8.30 | $0.1680 |
| Market cap | $8.5M | $7.5M |
| Today | −0.24% | +0.30% |
| 1 month | −12.9% | −36.2% |
| 6 months | −83.3% | −72.0% |
| Year to date | −87.5% | −74.6% |
| 1 year | −96.4% | −95.7% |
| Revenue growth (YoY) | — | +504.9% |
| Gross margin | — | 100.0% |
| Net margin | — | −882.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.0× |
| Net cash | $7.3M | $31.7M |
| Dividend yield | — | — |
| Volatility (60d) | 850.7% | 105.2% |
| Short % of float | 0.7% | 5.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).